Eric Yan
Overview
Explore the profile of Eric Yan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wilton-Clark H, Yan E, Yokota T
Genes (Basel)
. 2024 Jul;
15(7).
PMID: 39062600
The process of developing therapies to treat rare diseases is fraught with financial, regulatory, and logistical challenges that have limited our ability to build effective treatments. Recently, a novel type...
2.
Okafor L, Yan E
Ann Tour Res
. 2022 May;
95:103424.
PMID: 35600093
This study explores whether vaccination coverage, social distancing rules, and COVID-19 death rate affect tourism recovery using data from 249 countries/territories. We used panel data regression techniques-namely Fixed-effects, Hausman-Taylor, and...
3.
Yan E, Kuo D
J Med Ethics
. 2019 Feb;
45(4):219-224.
PMID: 30796090
In this article, we discuss the ethical dimensions for the prescribing behaviours of opioids for a chronic pain patient, a scenario commonly witnessed by many physicians. The opioid epidemic in...
4.
Kantarjian H, Su Y, Jabbour E, Bhattacharyya H, Yan E, Cappelleri J, et al.
Cancer
. 2018 Mar;
124(10):2151-2160.
PMID: 29508899
Background: Inotuzumab ozogamicin (InO), an anti-CD22 antibody-calicheamicin conjugate, demonstrated superior clinical activity versus standard-of-care (SOC) chemotherapies for relapsed/refractory B-cell acute lymphoblastic leukemia in the phase 3 randomized controlled INO-VATE trial....
5.
Carpenter C, Yan E, Chen S, Hong K, Arechiga A, Kim W, et al.
J Obes
. 2013 May;
2013:790654.
PMID: 23691288
Obesity prevalence and average body composition vary by US race and gender. Asian Americans have the lowest prevalence of obesity. Relying on body-mass index (BMI) to estimate obesity prevalence may...
6.
Maeda-Chubachi T, Chi-Burris K, Simons B, Bremond-Gignac D, Freedman S, Khaw P, et al.
J Glaucoma
. 2013 Mar;
22(8):614-9.
PMID: 23524858
Purpose: To evaluate the impact of age, glaucoma-specific diagnosis, and history of prior glaucoma surgery on outcomes in pediatric patients treated with latanoprost monotherapy. Patients And Methods: Prospective, randomized, double-masked...
7.
Nguyen Q, Schachar R, Nduaka C, Sperling M, Basile A, Klamerus K, et al.
Invest Ophthalmol Vis Sci
. 2012 Oct;
53(12):7666-74.
PMID: 23074206
Purpose: To evaluate the safety and efficacy of three doses of PF-04523655, a 19-nucleotide methylated double stranded siRNA targeting the RTP801 gene, for the treatment of diabetic macular edema (DME)...
8.
Nguyen Q, Schachar R, Nduaka C, Sperling M, Klamerus K, Chi-Burris K, et al.
Ophthalmology
. 2012 Jun;
119(9):1867-73.
PMID: 22683252
Objective: To evaluate the efficacy of different dosing paradigms of PF-04523655 (PF) versus ranibizumab (comparator) in subjects with neovascular age-related macular degeneration (AMD). Design: Multicenter, open-label, prospective, randomized, comparator-controlled exploratory...
9.
Kumar V, Ananthakrishnan S, Rasgon S, Yan E, Burchette R, Dewar K
Perit Dial Int
. 2011 Oct;
32(2):137-41.
PMID: 21965618
Background: We sought to compare perioperative outcomes and 2-year survival in a cohort of peritoneal dialysis (PD) patients compared with matched hemodialysis (HD) patients who underwent cardiothoracic surgery at our...
10.
Maeda-Chubachi T, Chi-Burris K, Simons B, Freedman S, Khaw P, Wirostko B, et al.
Ophthalmology
. 2011 Jun;
118(10):2014-21.
PMID: 21680022
Objective: To compare the efficacy and safety of latanoprost versus timolol in pediatric patients with glaucoma. Design: Prospective, randomized, double-masked, 12-week, multicenter study. Participants: Individuals aged ≤18 years with glaucoma....